Neutralization of infectivity of porcine circovirus type 2 (PCV2) by capsid-binding 2′F-RNA aptamers

Antiviral Research

Volumn 88, Issue 1, 2010, Pages 19-24

  Yoon, Sorah ^a,c   Lee, Garam ^a   Han, Dongun ^b   Song, Jae Young ^a   Kang, Kyung Sun ^c   Lee, Yong Soon ^c  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Cheonan Yonam College   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

2 F RNA aptamer; Neutralization; PCV2; Therapeutic agents

Indexed keywords

2' FLUOROPYRIMIDINE RNA APTAMER; APTAMER; CAPSID PROTEIN; FLUOROPYRIMIDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CIRCOVIRUS; COMBINATORIAL LIBRARY; DOSE RESPONSE; GEL MOBILITY SHIFT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; CAPSID; CAPSID PROTEINS; CELL LINE; CIRCOVIRUS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; POLYMERASE CHAIN REACTION; PYRIMIDINES; RECOMBINANT PROTEINS; RNA; SEQUENCE ANALYSIS, DNA; SWINE; VIRULENCE; VIRUS REPLICATION;

MIRIDAE; PORCINE CIRCOVIRUS; PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 77956910981     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.06.012     Document Type: Article

References (20)

1. Allan G.M., Kennedy S., McNeilly F., Foster J.C., Ellis J.A., Krakowka S.J., Meehan B.M., Adair B.M. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J. Comp. Pathol. 1999, 121:1-11.
2. Brunborg I.M., Moldal T., Jonassen C.M. Quantitation of porcine circovirus type 2 isolated from serum/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR. J. Virol. Methods 2004, 122:171-178.
3. Chu T.C., Twu K.Y., Ellington A.D., Levy M. Aptamer mediated siRNA delivery. Nucleic Acids Res. 2006, 34:e73.
4. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
5. Feng Z., Jiang P., Wang X., Li Y., Jiang W. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo. Antiviral Res. 2008, 77:186-194.
6. Hwang B., Lim J.H., Hahm B., Jang S.K., Lee S.W. hnRNP L is required for the translation mediated by HCV IRES. Biochem. Biophys. Res. Commun. 2009, 378:584-588.
7. Jeon S.H., Kayhan B., Ben-Yedidia T., Arnon R. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J. Biol. Chem. 2004, 279:48410-48419.
8. Joshi P.J., North T.W., Prasad V.R. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol. Ther. 2005, 11:677-686.
9. Khati M., Schuman M., Ibrahim J., Sattentau Q., Gordon S., James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2′F-RNA aptamers. J. Virol. 2003, 77:12692-12698.
10. + T lymphocyte function. J. Immunol. 1998, 160:5209-5212.
11. Kyle P.Horsen S.S.D., Nietfeld J.C., Henry S.C., Steven C., Hesse R.A., Oberst R., Hays M., Anderson J., Rowland R.R.R. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 2008, 232:906-912.
12. Mankertz A., Mankertz J., Wolf K., Buhk H.J. Identification of a protein essential for replication of porcine circovirus. J. Gen. Virol. 1998, 79:381-384.
13. McNeilly F., McNair I., Mackie D.P., Meehan B.M., Kennedy S., Moffett D., Ellis J., Krakowka S., Allan G.M. Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. Arch. Virol. 2001, 146:909-922.
14. Mori T., Oguro A., Ohtsu T., Nakamura Y. RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res. 2004, 32:6120-6128.
15. Nawagitgul P., Morozov I., Bolin S.R., Harms P.A., Sorden S.D., Paul P.S. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J. Gen. Virol. 2000, 81:2281-2287.
16. Oguro A., Ohtsu T., Svitkin Y.V., Sonenberg N., Nakamura Y. RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA 2003, 9:394-407.
17. Pagratis N.C., Bell C., Chang Y.F., Jennings S., Fitzwater T., Jellinek D., Dang C. Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 1997, 15:68-73.
18. Sanchez R.E., Meerts P., Nauwynck H.J., Ellis J.A., Pensaert M.B. Characteristics of porcine circovirus-2 replication in lymphoid organs of pigs inoculated in late gestation or postnatally and possible relation to clinical and pathological outcome of infection. J. Vet. Diagn. Invest. 2004, 16:175-185.
19. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
20. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31:3406-3415.